How Might Anti-Obesity Medication Look Like in the Future?

From GLP-1 therapies to next-generation treatments and long-term weight management

Watch the full video on YouTube to explore the future of anti-obesity medications and emerging therapeutic strategies.

In this episode, experts, Dr. Daniela Liśkiewicz and Dr. Juan Pablo Frías discuss the rapid evolution of obesity pharmacotherapy, from GLP-1 receptor agonists to next-generation combination treatments and oral therapies.

Key topics include:

• The shift from injectable to oral and longer-acting medications
• Multi-agonist therapies targeting multiple metabolic pathways
• The importance of “quality weight loss” and preserving muscle mass
• Challenges in long-term weight maintenance and preventing regain
• The role of lifestyle intervention alongside pharmacotherapy
• Future targets, including metabolic “set point” regulation

Explore more about the speakers:

1. Dr Daniela Liśkiewicz
2. Dr Juan Pablo Frias

For more episodes, visit our podcast archive.